Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

The aim of this study was to evaluate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) oral spray for oral mucositis (OM) induced by intensive chemotherapy with hematopoietic stem cell transplantation. In this phase 2 study, patients were randomized to either rhEGF (50 mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Won, Kim, Myeong Gyu, Lee, Hyun Jung, Koh, Youngil, Kwon, Ji-Hyun, Kim, Inho, Park, Seonyang, Kim, Byoung Kook, Oh, Jung Mi, Kim, Kyung Im, Yoon, Sung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207736/
https://www.ncbi.nlm.nih.gov/pubmed/28045958
http://dx.doi.org/10.1371/journal.pone.0168854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207736/
https://www.ncbi.nlm.nih.gov/pubmed/28045958
http://dx.doi.org/10.1371/journal.pone.0168854

Ejemplares similares